The DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.
Germline Mutations in Predisposition Genes in Pediatric Cancer
Open accessAbstract
BACKGROUND: The prevalence and spectrum of predisposing mutations among children and adolescents with cancer are largely unknown. Knowledge of such mutations may improve the understanding of tumorigenesis, direct patient care, and enable genetic counseling of patients and families. METHODS: In 1120 patients younger than 20 years of age, we sequenced the whole genomes (in 595 patients), whole exomes (in 456), or both (in 69). We analyzed the DNA sequences of 565 genes, including 60 that have been associated with autosomal dominant cancer-predisposition syndromes, for the presence of germline mutations. The pathogenicity of the mutations was determined by a panel of medical experts with the use of cancer-specific and locus-specific genetic databases, the medical literature, computational predictions, and second hits identified in the tumor genome. The same approach was used to analyze data from 966 persons who did not have known cancer in the 1000 Genomes Project, and a similar approach was used to analyze data from an autism study (from 515 persons with autism and 208 persons without autism). RESULTS: Mutations that were deemed to be pathogenic or probably pathogenic were identified in 95 patients with cancer (8.5%), as compared with 1.1% of the persons in the 1000 Genomes Project and 0.6% of the participants in the autism study. The most commonly mutated genes in the affected patients were TP53 (in 50 patients), APC (in 6), BRCA2 (in 6), NF1 (in 4), PMS2 (in 4), RB1 (in 3), and RUNX1 (in 3). A total of 18 additional patients had protein-truncating mutations in tumor-suppressor genes. Of the 58 patients with a predisposing mutation and available information on family history, 23 (40%) had a family history of cancer. CONCLUSIONS: Germline mutations in cancer-predisposing genes were identified in 8.5% of the children and adolescents with cancer. Family history did not predict the presence of an underlying predisposition syndrome in most patients. (Funded by the American Lebanese Syrian Associated Charities and the National Cancer Institute.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The frequency of germline mutations in patients with osteosarcoma ranges from 18% to 28% and these mutations are more common in younger patients 12,18 .”
From Osteosarcoma (2022) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Enhancements and modifications of primer design program Primer3
Kõressaar, T., & Remm, M. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm091 · Cited by 2,618
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,544
Principles and Practice of Pediatric Oncology
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-8-636_3 · Cited by 2,034
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596
Self-citation
Flagged first, then by citations
2 of the 56 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Lindor NM, 2008, J Natl Cancer Inst Monogr, 1
- Meldrum C, 2011, Clin Biochem Rev, 32, 177
- Armes JE, 1999, Cancer Res, 59, 2011
Cited by
Sorted by citations
Items 301–400 of 1,000
Kim, J., Vaksman, Z., Egolf, L. E., Kaufman, R., Evans, P., Conkrite, K. L., Danesh, A., López, G., Randall, M. P., Dent, M. H., et al. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad183 · Cited by 35
Rare, Pathogenic Germline Variants in Fanconi Anemia Genes Increase Risk for Squamous Lung Cancer
Selvan, M. E., Klein, R. J., & Gumus, Z. H. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2660 · Cited by 30
Recent Advances in Pediatric Cancer Research
McEachron, T. A., & Helman, L. J. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1191 · Cited by 35
Advances in the Treatment of Pediatric Bone Sarcomas
Grohar, P. J., Janeway, K. A., Maese, L. D., & Schiffman, J. D. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175378 · Cited by 30
Mora, D. C., Kristoffersen, A. E., Overvåg, G., Jong, M. C., Mentink, M. D. C., Liu, J., & Stub, T. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354221105563 · Cited by 35
Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors
Nie, D., Guo, T., Yue, M., Li, W., Zong, X., Zhu, Y., Huang, J., & Lin, M. (2022) · Biomolecules · doi:10.3390/biom12091239 · Cited by 33
Ethical considerations surrounding germline next-generation sequencing of children with cancer
Johnson, L., Hamilton, K. V., Valdez, J. M., Knapp, E. E., Baker, J. N., & Nichols, K. E. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1316665 · Cited by 31
Self-citationPrecision Medicine in Pediatric Cancer: Current Applications and Future Prospects
Ahmed, A. A., Vundamati, D. S., Farooqi, M. S., & Guest, E. M. (2018) · Microarrays · doi:10.3390/ht7040039 · Cited by 31
Yang, C. G., Austin, F., Richard, H., Idowu, M. O., Williamson, V. S., Sabato, F., Ferreira‐Gonzalez, A., & Turner, S. A. (2019) · Molecular Case Studies · doi:10.1101/mcs.a003863 · Cited by 30
Elitzur, S., Shiloh, R., Loeffen, J. L. C., Pastorczak, A. K., Takagi, M., Bomken, S. N., Baruchel, A., Lehrnbecher, T., Tasian, S. K., Abla, O., et al. (2024) · Blood · doi:10.1182/blood.2024024283 · Cited by 27
InactivatingMUTYHgermline mutations in pediatric patients with high-grade midline gliomas
Kline, C., Joseph, N. M., Grenert, J. P., Ziffle, J. V., Yeh, I., Bastian, B. C., Mueller, S., & Solomon, D. A. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now013 · Cited by 29
Genotype–phenotype associations among panel-based TP53+ subjects
Rana, H. Q., Clifford, J., Hoang, L., LaDuca, H., Black, M. H., Li, S., McGoldrick, K., Speare, V., Dolinsky, J. S., Gau, C., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0541-y · Cited by 31
Sharp, K. M. H., Jurbergs, N., Ouma, A., Harrison, L., Gerhardt, E. L., Taylor, L., Hamilton, K. V., McGee, R., Nuccio, R., Quinn, E. A., et al. (2020) · JCO Precision Oncology · doi:10.1200/po.19.00213 · Cited by 22
Self-citationOn behalf of the European Intergroup for Childhood Non-Hodgkin’s Lymphoma (EICNHL) and the International Berlin-Frankfurt-Münster (i-BFM) Study Group, Attarbaschi, A., Carraro, E., Ronceray, L., Andrés, M., Barzilai‐Birenboim, S., Bomken, S. N., Brugières, L., Burkhardt, B., Ceppi, F., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0841-x · Cited by 29
European genetic ancestry associated with risk of childhood ependymoma
Zhang, C., Ostrom, Q. T., Hansen, H. M., Gonzalez‐Maya, J., Hu, D., Ziv, E., Morimoto, L. M., de Smith, A. J., Muskens, I. S., Kline, C., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa130 · Cited by 28
Familial myelodysplastic syndrome/acute myeloid leukemia
Churpek, J. E. (2017) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2017.10.002 · Cited by 30
Lin, F. Y. H., Bergstrom, K. L., Person, R., Bavle, A. A., Ballester, L. Y., Scollon, S., Raesz-Martinez, R., Jea, A. H., Birchansky, S. B., Wheeler, D. A., et al. (2016) · Molecular Case Studies · doi:10.1101/mcs.a001057 · Cited by 29
Kimura, S., Seki, M., Yoshida, K., Shiraishi, Y., Akiyama, M., Koh, K., Imamura, T., Manabe, A., Hayashi, Y., Kobayashi, M., et al. (2018) · Cancer Science · doi:10.1111/cas.13859 · Cited by 28
Molecular features of pleomorphic xanthoastrocytoma
Zou, H., Duan, Y., Wei, D., Zhang, Y., Dai, R., Li, J., Li, X., Zhou, J., Liu, Z., Jin, Z., et al. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.08.038 · Cited by 28
Chiriță-Emandi, A., Andreescu, N. I., Zimbru, C. G., Tutac, P., Arghirescu, S. T., Şerban, M., & Puiu, M. (2020) · Scientific Reports · doi:10.1038/s41598-019-57080-9 · Cited by 28
Bimodal Age Distribution in Cancer Incidence
Desai, S., & Guddati, A. K. (2022) · World Journal of Oncology · doi:10.14740/wjon1424 · Cited by 28
Rare germline structural variants increase risk for pediatric solid tumors
Gillani, R., Collins, R. L., Crowdis, J., Garza, A., Jones, J. K., Walker, M., Sanchis-Juan, A., Whelan, C., Pierce‐Hoffman, E., Talkowski, M. E., et al. (2025) · Science · doi:10.1126/science.adq0071 · Cited by 28
Hodgson, D. C., van Leeuwen, F. E., Ng, A. K., Morton, L. M., & Henderson, T. O. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175668 · Cited by 27
Goudie, C., Cullinan, N. M., Villani, A., Mathews, N., van Engelen, K., Malkin, D. M., Irwin, M. S., & Foulkes, W. D. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27390 · Cited by 29
Germline Predisposition to Hematolymphoid Neoplasia
Weinberg, O. K., Kuo, F. C., & Calvo, K. R. (2019) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqz067 · Cited by 27
Wilson, C. L., Wang, Z., Liu, Q., Ehrhardt, M. J., Mostafavi, R. M., Easton, J. B., Mulder, H. L., Hedges, D. J., Wang, S., Rusch, M., et al. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.28047 · Cited by 27
Self-citationPatient-Specific Multi-Omics Models and the Application in Personalized Combination Therapy
John, A. J., Qin, B., Kalari, K. R., Wang, L., & Yu, J. (2020) · Future Oncology · doi:10.2217/fon-2020-0119 · Cited by 27
Hasaart, K., Manders, F., van der Hoorn, M., Verheul, M., Poplonski, T., Kuijk, E., Lopes, S. M. C. D. S., & van Boxtel, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-69822-1 · Cited by 29
YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas
Schieffer, K. M., Agarwal, V., LaHaye, S., Miller, K. E., Koboldt, D. C., Lichtenberg, T. M., Leraas, K., Brennan, P. J., Kelly, B., Crist, E. R., et al. (2020) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001597 · Cited by 27
Self-citationBiomarkers and Corresponding Biosensors for Childhood Cancer Diagnostics
Gharehzadehshirazi, A., Zarejousheghani, M., Falahi, S., Joseph, Y., & Rahimi, P. (2023) · Sensors · doi:10.3390/s23031482 · Cited by 27
B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers
Chou, W., Chen, W., Hsiung, C., Hu, L., Yu, J., Hsu, H.-M., & Shen, C. (2017) · Scientific Reports · doi:10.1038/srep44089 · Cited by 27
Depicting the genetic architecture of pediatric cancers through an integrative gene network approach
Savary, C., Kim, A., Lespagnol, A., Gandemer, V., Pellier, I., Andrieu, C., Pagès, G., Galibert, M., Blum, Y., & de Tayrac, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-58179-0 · Cited by 31
The Financial Impact of Genetic Diseases in a Pediatric Accountable Care Organization
Miller, K. E., Hoyt, R., Rust, S., Doerschuk, R., Huang, Y., & Lin, S. M. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00058 · Cited by 26
Morton, L. M., Karyadi, D. M., Hartley, S. W., Frone, M. N., Sampson, J. N., Howell, R. M., Neglia, J. P., Arnold, M., Hicks, B. D., Jones, K. M., et al. (2020) · JCO Precision Oncology · doi:10.1200/po.20.00141 · Cited by 26
Waespe, N., Belle, F. N., Redmond, S. M. S., Schindera, C., Spycher, B. D., Rössler, J. K., Ansari, M., Kuehni, C. E., Ansari, M., Popovic, M. B., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2020.11.042 · Cited by 26
Berrino, E., Filippi, R., Visintin, C., Peirone, S., Fenocchio, E., Farinea, G., Veglio, F., Aglietta, M., Sapino, A., Cereda, M., et al. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00258-8 · Cited by 26
BARD1germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma
Randall, M. P., Egolf, L. E., Vaksman, Z., Samanta, M., Tsang, M., Groff, D., Evans, P., Rokita, J. L., Layeghifard, M., Shlien, A., et al. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad182 · Cited by 25
Adult-Onset Cancer Predisposition Syndromes in Children and Adolescents—To Test or not to Test?
Kratz, C. P., Lupo, P. J., Zelley, K., Schienda, J., Nichols, K. E., Stewart, D. R., Malkin, D. M., Brodeur, G. M., Maxwell, K. N., Plon, S. E., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3683 · Cited by 26
Self-citationThe future of clinical cancer genomics
Offit, K. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.10.002 · Cited by 27
Postema, F. A. M., Hopman, S. M. J., Aalfs, C. M., Berger, L. P. V., Bleeker, F. E., Dommering, C. J., Jongmans, M. C. J., Letteboer, T. G. W., Olderode-Berends, M. J. W., Wagner, A., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.04.021 · Cited by 26
Postema, F. A. M., Hopman, S. M. J., Hennekam, R. C. M., & Merks, J. H. M. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26718 · Cited by 26
Pritchard, A. L., Johansson, P. A., Nathan, V., Howlie, M., Symmons, J., Palmer, J. M., & Hayward, N. K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194098 · Cited by 26
Byrjalsen, A., Stoltze, U. K., Wadt, K., Hjalgrim, L. L., Gerdes, A., Schmiegelow, K., & Wahlberg, A. (2018) · European Journal of Cancer Care · doi:10.1111/ecc.12877 · Cited by 26
Allodji, R. S., Haddy, N., Vu‐Bezin, G., Dumas, A., Fresneau, B. C., Mansouri, I., Demoor‐Goldschmidt, C., El‐Fayech, C., Pacquement, H., Münzer, M., et al. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27495 · Cited by 26
Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in children
de Smith, A. J., Lavoie, G., Walsh, K. M., Aujla, S. K., Evans, E., Hansen, H. M., Smirnov, I. V., Kang, A. Y., Zenker, M., Ceremsak, J. J., et al. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22765 · Cited by 30
Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer
Sheng, S., Xu, Y., Guo, Y., Yao, L., Hu, L., Ouyang, T., Li, J., Wang, T., Fan, Z., Fan, T., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32424 · Cited by 26
Enrichment of heterozygous germline RECQL4 loss-of-function variants in pediatric osteosarcomaPreprint
Maciaszek, J. L., Oak, N., Chen, W., Hamilton, K. V., McGee, R. B., Nuccio, R., Mostafavi, R. M., Hines‐Dowell, S. J., Harrison, L. W., Taylor, L. M., et al. (2019) · Molecular Case Studies · doi:10.1101/mcs.a004218 · Cited by 26
Self-citationRe-envisioning genetic predisposition to childhood and adolescent cancers
Kratz, C. P. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00775-7 · Cited by 29
Toward an Effective Ebola Virus Vaccine
Keshwara, R., Johnson, R. F., & Schnell, M. J. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-051215-030919 · Cited by 25
Weber, E., Shuman, C. T., Wasserman, J. D., Barrera, M. E., Patenaude, A. F., Fung, K., Chitayat, D. A., Malkin, D. M., & Druker, H. A. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27445 · Cited by 25
von Stedingk, K., Stjernfelt, K.-J., Kvist, A., Wahlström, C., Kristoffersson, U., Stenmark‐Askmalm, M., Wiebe, T., Hjorth, L., Köster, J., Olsson, H. L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84502-4 · Cited by 24
Cushman‐Vokoun, A. M., Lauring, J. D., Pfeifer, J. D., Olson, D. R., Berry, A. B., Thorson, J., Voelkerding, K. V., Myles, J. L., Barbeau, J. M., Chandra, P., et al. (2021) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0025-cp · Cited by 25
A Review of Breast Cancer Risk Factors in Adolescents and Young Adults
McVeigh, U. M., Tepper, J. W., & McVeigh, T. P. (2021) · Cancers · doi:10.3390/cancers13215552 · Cited by 29
Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia
Watanabe‐Smith, K., Tognon, C. E., Tyner, J. W., Meijerink, J. P. P., Druker, B. J., & Agarwal, A. (2016) · Leukemia · doi:10.1038/leu.2016.95 · Cited by 25
Cancer gene mutations in congenital pulmonary airway malformation patients
Hsu, J. S., Zhang, R., Yeung, F., Tang, C. S.-M., Wong, J., So, M., Xia, H., Sham, P. C., Tam, P. K. H., Li, M., et al. (2019) · ERJ Open Research · doi:10.1183/23120541.00196-2018 · Cited by 25
Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice
Schratz, K. E., & Dezern, A. E. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.10.002 · Cited by 26
Rotunno, M., Barajas, R., Clyne, M., Hoover, E., Simonds, N. I., Lam, T. K., Mechanic, L. E., Goldstein, A. M., & Gillanders, E. M. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1551 · Cited by 25
Sánchez-Guixé, M., Muiños, F., Pinheiro-Santin, M., González-Huici, V., Rodriguez-Hernandez, C. J., Avgustinova, A., Lavarino, C., González-Pérez, A., Mora, J., & López-Bigas, N. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1186 · Cited by 15
Tesi, B., Lagerstedt‐Robinson, K., Abel, F., de Ståhl, T. D., Orrsjö, S., Poluha, A., Hellberg, M., Wessman, S., Samuelsson, S., Frisk, T., et al. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.100881 · Cited by 24
Zelley, K., Schienda, J., Gallinger, B., Kohlmann, W. K., McGee, R. B., Scollon, S., & Schneider, K. W. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1165 · Cited by 24
Self-citationPrecision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies
Tran, T. H., Shah, A. T., & Loh, M. L. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0115 · Cited by 24
Precision medicine in pediatric solid cancers
Blattner-Johnson, M., Jones, D., & Pfaff, E. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.008 · Cited by 26
Marron, M., Brackmann, L. K., Schwarz, H., Hummel-Bartenschlager, W., Zahnreich, S., Galetzka, D., Schmitt, I. M., Grad, C., Drees, P., Hopf, J. C., et al. (2021) · JMIR Research Protocols · doi:10.2196/32395 · Cited by 24
Fanconi Anaemia, Childhood Cancer and the BRCA Genes
Woodward, E. R., & Meyer, S. (2021) · Genes · doi:10.3390/genes12101520 · Cited by 27
Baliga, S., Gallotto, S. L., Bajaj, B. V. M., Lewy, J. R., Weyman, E. A., Lawell, M. P., Yeap, B. Y., Ebb, D., Huang, M., Caruso, P. A., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab257 · Cited by 24
Bonfiglio, F., Lasorsa, V. A., Cantalupo, S., D’Alterio, G., Aievola, V., Boccia, A. S., Ardito, M., Furini, S., Renieri, A., Morini, M., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104395 · Cited by 25
Hawkins, M. M., Bhatia, S., Henderson, T. O., Nathan, P. C., Yan, A. P., Teepen, J. C., & Morton, L. M. (2020) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2020.07.006 · Cited by 25
Gajjar, A. J., Mahajan, A., Bale, T., Bowers, D. C., Canan, L., Chi, S. N., Cluster, A. S., Cohen, K. J., Cole, B., Coven, S. L., et al. (2025) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2025.0012 · Cited by 23
Self-citationPrecision oncology: lessons learned and challenges for the future
Yang, H., Shah, R. H., Tegay, D. H., & Onel, K. (2019) · Cancer Management and Research · doi:10.2147/cmar.s201326 · Cited by 25
Causes of death in pediatric neuro-oncology: the sickkids experience from 2000 to 2017
Renzi, S., Michaeli, O., Ramaswamy, V., Huang, A., Stephens, D., Maguire, B. R., Tabori, U. Y., Bouffet, É., & Bartels, U. K. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03590-w · Cited by 23
Diessner, B. J., Weigel, B. J., Murugan, P. J., Zhang, L., Poynter, J. N., & Spector, L. G. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0520 · Cited by 21
Screening of cancer predisposition syndromes
Al-Sarhani, H., Gottumukkala, R. V., Grasparil, A. D. I., Tung, E. L., Gee, M. S., & Greer, M. C. (2021) · Pediatric Radiology · doi:10.1007/s00247-021-05023-w · Cited by 23
Genetic predisposition to lymphomas: Overview of rare syndromes and inherited familial variants
Szmyd, B. M., Mlynarski, W. M., & Pastorczak, A. K. (2021) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2021.108386 · Cited by 23
The impact of mitochondria on cancer treatment resistance
van der Merwe, M., van Niekerk, G., Fourie, C., du Plessis, M., & Engelbrecht, A. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00623-y · Cited by 24
Chen, W., Wang, S., Tithi, S. S., Ellison, D. W., Schaid, D. J., & Wu, G. (2022) · Nature Communications · doi:10.1038/s41467-022-30248-0 · Cited by 25
Self-citationTrio sequencing in pediatric cancer and clinical implications
Kuhlen, M., & Borkhardt, A. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708641 · Cited by 23
The Iceberg Map of germline mutations in childhood cancer: focus on primary immunodeficiencies
Kindler, O., Quehenberger, F., Benesch, M., & Seidel, M. G. (2018) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000680 · Cited by 23
Chen, L., Xu, B., Long, X., Gu, J., Lou, Y., Wang, D., Cao, Y., Wang, N., Li, C., Wang, G., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000364 · Cited by 23
Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact
Hattinger, C. M., Patrizio, M. P., Luppi, S., & Serra, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134659 · Cited by 23
Imaging of cancer predisposition syndromes
Greer, M. C. (2018) · Pediatric Radiology · doi:10.1007/s00247-018-4113-0 · Cited by 22
Genes at the Crossroad of Primary Immunodeficiencies and Cancer
Derpoorter, C., Bordon, V., Laureys, G., Haerynck, F., & Lammens, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02544 · Cited by 23
RNAIndel: discovering somatic coding indels from tumor RNA-Seq data
Hagiwara, K., Ding, L., Edmonson, M. N., Rice, S. V., Newman, S., Easton, J. B., Dai, J., Meshinchi, S., Ries, R. E., Rusch, M., et al. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz753 · Cited by 21
Self-citationImaging surveillance for children with predisposition to renal tumors
Srinivasan, A. S., Saade-Lemus, S. M., Servaes, S. E., Acord, M. R., Reid, J. R., Anupindi, S. A., & States, L. J. (2019) · Pediatric Radiology · doi:10.1007/s00247-019-04432-2 · Cited by 22
Genetic syndromes predisposing to pediatric brain tumors
Sait, S. F., Walsh, M. F., & Karajannis, M. A. (2021) · Neuro-Oncology Practice · doi:10.1093/nop/npab012 · Cited by 23
Self-citationBarreto, S. G., & Pandol, S. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.653289 · Cited by 22
Mandrell, B. N., Gattuso, J. S., Pritchard, M., Caples, M., Sharp, K. M. H., Harrison, L. W., Ouma, A. A., Valdez, J. M., Johnson, L., & Nichols, K. E. (2021) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2021.151167 · Cited by 22
Self-citationRegulation of Molecular Targets in Osteosarcoma Treatment
Çelik, B., Cicek, K., Leal, A. F., & Tomatsu, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012583 · Cited by 22
Moke, D. J., Hamilton, A. S., Chehab, L. M., Deapen, D., & Freyer, D. R. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0466 · Cited by 22
Castellanos, E., Rosas, I., Negro, A., Gel, B., Alibés, A., Baena, N., Pineda, M., Pi, G., Pintos‐Morell, G., Salvador, H., et al. (2019) · Clinical Genetics · doi:10.1111/cge.13649 · Cited by 22
Grasparil, A. D. I., Gottumukkala, R. V., Greer, M. C., & Gee, M. S. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.19.22399 · Cited by 22
Infantile fibrosarcoma–like tumor driven by novel RBPMS-MET fusion consolidated with cabozantinibPreprint
Gupta, A. K., Belsky, J. A., Schieffer, K. M., Leraas, K., Varga, E., McGrath, S. D., Koo, S. C., Magrini, V. J., Wilson, R. K., White, P., et al. (2020) · Molecular Case Studies · doi:10.1101/mcs.a005645 · Cited by 22
Self-citationWang, T., He, Y., Xue, W., Zhang, J., Xia, Y., Deng, C., Zhang, W., Xiao, R., Liao, Y., Yang, D.-W., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac177 · Cited by 21
Self-citationHalverson, C. M. E., Wessinger, B. C., Clayton, E. W., & Wiesner, G. L. (2019) · Journal of Genetic Counseling · doi:10.1002/jgc4.1174 · Cited by 21
Ewing’s Sarcoma as a Second Malignancy in Long-Term Survivors of Childhood Hematologic Malignancies
Wolpert, F., Grotzer, M. A., Niggli, F. K., Zimmermann, D. R., Rushing, E. J., & Bode‐Lesniewska, B. (2016) · Sarcoma · doi:10.1155/2016/5043640 · Cited by 21
A case for expert curation: an overview of cancer curation in the Clinical Genome Resource (ClinGen)Preprint
Ritter, D., Rao, S., Kulkarni, S., Madhavan, S., Offit, K., & Plon, S. E. (2019) · Molecular Case Studies · doi:10.1101/mcs.a004739 · Cited by 21
Sumerauer, D., Krsková, L., Vícha, A., Mišove, A., Mamatjan, Y., Jenčová, P., Vlčková, M., Slámová, L., Váňová, K., Libý, P., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-019-02118-5 · Cited by 20
Basic research in childhood cancer: Progress and future directions in China
Jin, Y., & Lyu, Q. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.08.014 · Cited by 23
Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel
Byrjalsen, A., Diets, I. J., Bakhuizen, J. J., Hansen, T. V. O., Schmiegelow, K., Gerdes, A., Stoltze, U. K., Kuiper, R. P., Merks, J. H. M., Wadt, K., et al. (2021) · Familial Cancer · doi:10.1007/s10689-021-00254-0 · Cited by 20
In Utero Development and Immunosurveillance of B Cell Acute Lymphoblastic Leukemia
Rüchel, N., Jepsen, V. H., Hein, D., Fischer, U., Borkhardt, A., & Gössling, K. L. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-00963-3 · Cited by 21
Stoltze, U. K., Foss-Skiftesvik, J., Hansen, T. V. O., Byrjalsen, A., Sehested, A. M., Scheie, D., Mikkelsen, T. S., Rasmussen, S., Bak, M., Okkels, H., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac187 · Cited by 20
Metadata
- Authors
- Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., Wilkinson, M. R., Vadodaria, B., Chen, X., McGee, R. B., Hines-Dowell, S., Nuccio, R., Quinn, E., Shurtleff, S. A., Rusch, M., Patel, A., Becksfort, J. B., Wang, S., Weaver, M. S., Ding, L., Mardis, E. R., Wilson, R. K., Gajjar, A., Ellison, D. W., Pappo, A. S., Pui, C.-H., Nichols, K. E., & Downing, J. R.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Washington University in St. Louis (US)
- ORCID
- Zhang, Jinghui
- Walsh, Michael F.
- Wu, Gang
- Edmonson, Michael N.
- Gruber, Tanja A.
- Easton, John
- Ma, Xiaotu
- Zhou, Xin
- Yergeau, Donald A.
- Wilkinson, Mark R.
- Chen, Xiang
- McGee, Rose B.
- Nuccio, Regina
- Quinn, Emily
- Rusch, Michael
- Patel, Aman
- Becksfort, Jared B.
- Weaver, Meaghann S.
- Ding, Li
- Mardis, Elaine R.
- Wilson, Richard K.
- Gajjar, Amar
- Ellison, David W.
- Pappo, Alberto S.
- Pui, Ching-Hon
- Nichols, Kim E.
- Downing, James R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-12-10
- Volume
- 373
- Issue
- 24
- Pages
- 2336-2346
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4734119
- OpenAlex
- W2303408208
- Cited by
- 1,345
- References
- 56
- Citations by year
- 2026: 90 · 2025: 113 · 2024: 151 · 2023: 132 · 2022: 134 · 2021: 161 · 2020: 141 · 2019: 122 · 2018: 113 · 2017: 101 · 2016: 76 · 2015: 5
- FWCI
- 67.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Funders
- St. Jude Children's Research Hospital (CA21765)
- American Lebanese Syrian Associated Charities (CA 21765)
- National Cancer Institute (R01CA180006, CA21765, P30CA021765)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- germline mutations, cancer susceptibility genes, childhood cancer, children and adolescents, TP53, APC, BRCA2, neurofibromatosis type 1, PMS2, RB1, RUNX1, tumor suppressor, pathogenicity assessment, family history of cancer, genetic counseling, autism spectrum disorder
- MeSH terms
- Adolescent, Autistic Disorder, Child, Female, Genes, Dominant, Humans, Male, Neoplasms, Genome, Human, Sequence Analysis, DNA, Germ-Line Mutation, SEER Program, Genetic Predisposition to Disease, Genes, Neoplasm, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
